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Human papillomaviruses (HPVs) have previously been shown to adsorb to cultured cells via membrane-associated heparan sulfate (HS) and a6
integrin. We demonstrate that cultured keratinocytes uniquely secrete a component into the basal extracellular matrix (ECM) which can function to
adsorb HPV particles which can then be internalized by adherent cells. This uncharacterized basal ECM adsorption receptor was secreted by
normal human epidermal keratinocytes (NHEK) and by each of the four keratinocyte-derived cell lines we examined, but not by non-keratinocyte
cell lines. Multiple HPV types bound preferentially to this keratinocyte-specific receptor over the membrane-associated receptor, and binding to
the basal ECM adsorption receptor was refractory to inhibition by heparin. Like the membrane-associated receptor, this basal ECM component
was functional as an adsorption receptor in our in vitro infection model using HPV-11. Unlike particle adsorption, however, successful infection
with HPV-11 virions remained sensitive to the pretreatment of virions with heparin. The secreted basal ECM receptor did not colocalize with
antibodies against HS, perlecan, or a6 integrin, but colocalized with antibody against laminin-5, a marker of keratinocyte ECM and an abundant
component of the basement membrane in mucosa and skin. These findings suggest a model for natural infections in which HPV virions,
nonspecifically adsorbed to HS on suprabasal keratinocytes throughout an epithelial wound, might be transferred to mitotically active migrating
keratinocytes via an intermediate association with the ECM secreted by these cells as they reestablish the basement membrane.
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Successful viral infection requires the targeting of virions to
host cells that are capable of supporting the virus life cycle.
Because papillomavirus replication is restricted to terminally
differentiating epithelium of the skin or mucosa, productive
infection probably requires that virions gain access to the
mitotically active basal cells. It is currently unknown if virions
are able to target themselves to basal keratinocytes and avoid
uptake by suprabasal cells.
Several in vitro infection models have demonstrated that
HPV particles can utilize HS on heparan sulfate proteoglycans0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: ndc1@psu.edu (N.D. Christensen).(HSPGs) for their adsorption to cultured cells (Combita et al.,
2001; Drobni et al., 2003; Giroglou et al., 2001; Joyce et al.,
1999; Shafti-Keramat et al., 2003). In both skin and mucosa,
HSPG expression is not limited to the basal layer but is seen
throughout the epithelium (Andriessen et al., 1997; Oksala et al.,
1995). Consistent with these observations, HPV-6 virus-like
particles (VLPs) were shown to bind nonspecifically to cells
throughout the epithelium with no obvious concentration at the
basal layer (Evander et al., 1997). Taken together, these findings
have led to a model of natural infection in which receptor
specificity plays no significant role in targeting HPV virions to
mitotically active basal cells. It is generally supposed that natural
infections occur only in the rare event that wounding allows
virions to access and adsorb directly to the basal keratinocytes.
At least on suspended cells, a6 integrin (CD49f) can
function as an HPV adsorption receptor (Evander et al.,6) 147 – 159
www.e
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which is expressed throughout the epithelium, a6 integrin
expression is largely restricted to basal keratinocytes where it
plays a critical role in hemidesmosomes through direct
interactions with laminin-5 (LN5) in the basement membrane
(BM) (reviewed in Jones et al., 1998). It was previously
hypothesized that a6 integrin on migrating keratinoctyes might
facilitate the endocytosis of HPV virions by these cells, thereby
targeting virions to cells capable of permissive infection
(Evander et al., 1997). At least two in vitro infection models
have demonstrated that adherent cells not expressing a6
integrin are capable of supporting papillomavirus entry and
uncoating (Shafti-Keramat et al., 2003; Sibbet et al., 2000). It is
not known, however, whether virion uptake by these cell lines
is unaltered in efficiency and pathway, nor whether a6 integrin,
polarized to the basal membrane in vitro, plays a role in the
infection of adherent cells which express it.
The present studies were initiated to assess whether HS
plays a role in the infection of HaCaT cells by HPV-11 virions.
It is known that HPV-11 L1 VLPs can bind HS on HaCaT cells
(Joyce et al., 1999) and that HPV-11 virions infect at least one
keratinocyte cell line (KH-SV) via an HS-dependent pathway
(Shafti-Keramat et al., 2003). A recent report, however,
concluded that HPV-31b infection of adherent HaCaT cells
occurs via an HS-independent pathway (Patterson et al., 2005).
Because many previous HPV receptor studies have utilized
HaCaT and COS-7 cells, we chose to focus our experiments on
these two cell lines to facilitate more direct comparison (Drobni
et al., 2004; Giroglou et al., 2001; Joyce et al., 1999; Patterson
et al., 2005). An approach combining immunofluorescence
studies with infection assays was chosen to correlate visible
‘‘snapshots’’ of the cell surface with the progressive events of
infection. Authentic HPV-11 virions were used for the
infectivity experiments with transient infection assayed by
quantitative RT-PCR (QRT-PCR) (Culp and Christensen,
2003). Potential cytotoxic effects of the various treatments
were monitored by comparing RNAyields, relative levels of an
endogenous cellular transcript (TBP), in addition to visual
inspection. Immunocytochemistry and immunohistochemistry
were performed using surrogate particles (VLPs or pseudovir-
ions) of several HPV types. Adherent cells were utilized in all
experiments in order to avoid the loss of membrane-associated
and extracellular matrix (ECM) proteins during detachment of
cells from the culture substrate.
In the first section of this report, we show evidence
confirming the HPV-11 infection of both HaCaT and COS-7
monolayers appears to involve HS-associated receptors. Both
adsorption and infection via the apical surface of HaCaT
monolayers can be disrupted by pretreatment of cells with
heparinase I or protamine or by pretreatment of virions with
heparin. Adsorption and infection via the apical receptor were
enhanced by pretreatment of uninfected monolayers with 10
mM sodium chlorate or heparin prior to infection.
While performing the above experiments, however, we
discovered that HaCaT cells, unlike COS-7 cells, secreted an
additional HPV adsorption receptor into the basal ECM which
is preferentially bound relative to the membrane-associatedreceptor. Further investigation revealed that this basal ECM
receptor is secreted by at least four keratinocyte-derived cell
lines, and by NHEKs, but not by non-keratinocyte cell lines.
This secreted HPVadsorption receptor colocalizes with laminin
5 (LN5), but not with a6 integrin, a3 integrin, HS, perlecan, or
BM-HSPG. Virus particle binding to the basement membrane
of human cervical sections also occurred with a pattern
resembling LN5 staining. These data support the proposal of
a keratinocyte-specific receptor for HPVs, distinct from HS or
a6 integrin (Patterson et al., 2005). Finally, we demonstrate
that this novel HPV adsorption receptor can function to bind
HPV-11 virions which can then infect adjacent cells.
Results
Inhibition of HS-mediated HPV-11 adsorption/infection using
confluent monolayers
These studies began with an effort to determine if HS is
involved in the infection of HaCaT cells by authentic HPV-11
virions. Pretreatment of cells with heparinase I reduced HPV
particle binding and infection in several in vitro infection
models (Giroglou et al., 2001; Joyce et al., 1999; Shafti-
Keramat et al., 2003). A recent report, however, showed that,
while heparinase I treatment blocked HPV-31b infection of
COS-7 cells, the treatment had little, if any, effect on infection
of subconfluent HaCaT cells (Patterson et al., 2005).
Monolayers of HaCaT and COS-7 cells were pretreated with
heparinase I for various timepoints prior to infection. HPV-11
virions were then adsorbed to treated monolayers for 6 h at a
multiplicity of 150 particles/cell. To monitor the effects of the
treatment on cell surface HS, companion monolayers seeded on
coverslips were simultaneously treated and subsequently
stained for HS. We have shown previously with this particular
infection model that virions adsorb slowly with only one-half
of the input virions successfully bound to untreated monolayers
within 6 h (Culp and Christensen, 2004). While it is possible to
detect HPV-11 viral transcripts by QRT-PCR using shorter
adsorption periods, E1^E4 transcript levels are reduced, and
error between replicate wells can be greatly increased.
Allowing 6 h for viral adsorption greatly increased reproduc-
ibility of results in our hands, albeit at the expense of allowing
monolayers a degree of recovery from the pretreatment. We did
not attempt to treat monolayers during the adsorption period in
order to avoid any direct effects of the treatment on virion
particles.
Unlike what was previously shown for HPV-31b infection
(Patterson et al., 2005), we reproducibly found that heparinase
pretreatment led to a partial, but statistically significant
reduction in successful HPV-11 infection of HaCaT cells
(Fig. 1a). Consistent with previous reports, this treatment led
to a near complete block in the infection of COS-7 cells. This
suggests at least a limited role for HS in the infection of HaCaT
monolayers by HPV-11 in agreement with previous findings
using HPV-11 and KH-SV keratinocytes. The distinct sensi-
tivities of HPV-11 infection of the two cell lines following
heparinase I treatment may be due to a more rapid recovery of
Fig. 1. Inhibition of HPV-11 infection by heparinase I. (a) Uninfected duplicate
wells of HaCaT and COS-7 monolayers were rinsed and covered with KCl-
containing isotonic buffer and incubated at 37 -C. At selected timepoints, 1 U
of freshly reconstituted heparinase I was added. Times shown indicate total
period of exposure to enzyme. After 60 min, all wells were repeatedly rinsed
prior to infection with HPV-11 in standard medium. After 6 h at 37 -C, the
unattached virions were removed by rinsing, and cells were given fresh
medium. Medium containing neutralizing MAb (H11.H3) was added at 18 h p.i.
RNA was harvested 2 days p.i. and analyzed by QRT-PCR. Heparinase I
treatment did not affect RNA yields or Ct values for TBP (not shown).
Asterisks (*) indicate P < 0.05 compared to mock-treated controls. (b)
Companion monolayers grown on glass coverslips and treated alongside
monolayers described above were either fixed with methanol immediately (0 h)
after heparinase I treatment or given fresh medium and incubated for 6 h at
37 -C prior to methanol fixation. Following fixation, coverslips were stained
for HS using F58-10E4. (red) and Hoechst 33342 (blue). Reproducibly,
staining with F58-10E4 led to heterogeneous staining, especially with COS-7
cells. Regardless, coverslips exposed to heparinase I digestion showed
reduced staining 0 h after treatment verifying enzyme activity. Scale bar
represents 50 A m. 
T.D. Culp et al. / Virology 347 (2006) 147–159 149cell surface HS by HaCaT cells during the 6 h adsorption
period (Fig. 1b).
As an additional strategy for inhibiting an HS-dependent
pathway, we examined the ability of HS ligands to inhibit
infection of HaCaT and COS-7 monolayers by HPV-11 virions.
An anti-HS MAb (F58-10E4), which targets the 10E4 epitope
of HS, reproducibly had no effect on HPV-11 infection of
either HaCaT or COS-7 cells when applied to monolayers at the
time of infection (data not shown). Pretreatment of cells withFig. 2. Competitive inhibition of HPV-11 adsorption/infection. (a) Uninfected
duplicate HaCaT and COS-7 monolayers were pretreated T protamine (50 or
10 Ag/ml) for 6 h at 37 -C. Treated monolayers were rinsed repeatedly prior
to infection with HPV-11 in standard medium. Monolayers were rinsed at 18
h to remove unattached virions and given fresh medium containing H11.H3.
(b) HPV-11 virions (sufficient for 150 particles/cell) were incubated with
serial dilutions of heparin for 1 h. Treated virions were then diluted with
medium and used to infect confluent monolayers of HaCaT and COS-7 cells.
Monolayers were rinsed at 6 h p.i. to remove unattached virions prior to
medium replacement. E1^E4 expression is shown relative to that of infection
resulting from vehicle (DMEM)-treated virions for each cell line (dashed
line). (c) HPV-11 virions were incubated T heparin (4 mg/ml) for 1 h.
Duplicate wells of confluent HaCaT and COS-7 monolayers were then
exposed to the treated virus for 6 h in standard medium (final heparin
concentration—5 Ag/ml) followed by rinsing and medium replacement. (d)
HPV-11 L1 VLPs were incubated T heparin for 1 h. HaCaT cells grown on
coverslips were fixed with methanol and then incubated with the treated
VLPs for 45 min followed by staining with anti-VLP (H11.B2). Scale bar
represents 10 Am. (a, b, and c) RNA was harvested 2 days p.i. and analyzed
by QRT-PCR for E1^E4 and TBP transcripts. Protamine and heparin did not
affect RNA yields or Ct values of TBP (not shown). Asterisks (*) indicate
P < 0.05 compared to mock-treated controls.
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effectively compete with HS-mediated binding on HaCaT cells
(Hausser et al., 1993), reproducibly blocked HPV-11 infection
of COS-7 cells and reduced 2-fold the infection of HaCaT cells
(Fig. 2a). Immunocytochemistry experiments revealed that
protamine reduced both HS-staining and VLP binding when
cells were stained immediately after treatment (data not
shown). The ability of protamine to inhibit infection of HaCaT
cells is in agreement with a recent report that lactoferrin,
another HS ligand, reduced binding and uptake of HPV-16
VLPs by suspended HaCaT cells (Drobni et al., 2004).
Heparin, a glycosaminoglycan (GAG) similar in composi-
tion to HS, has been shown to effectively bind HPV capsids
(Joyce et al., 1999). Consistent with previous reports using a
variety of HPV particles (Giroglou et al., 2001; Joyce et al.,
1999; Shafti-Keramat et al., 2003), the pretreatment of HPV-11
particles with heparin reduced both adsorption and infection ofFig. 3. Effect of sodium chlorate and heparin pretreatments on HPV-11 infection and
were given medium T 10 mM sodium chlorate. Cells were given the same medium
infected with HPV-11 virions in standard medium. Unbound virions were rinsed 12
grown on glass coverslips in medium T sodium chlorate for 42 h were rinsed, fixed,
H11.H3. Scale bar represents 10 Am. (c) Nearly confluent monolayers of HaCaT cells
infection with HPV-11 virions in standard medium. Fifteen h p.i. monolayers were ri
of nearly confluent HaCaT and COS-7 cells were pretreated T heparin (10 Ag/ml) fo
grown on glass coverslips were pretreated Theparin (10 Ag/ml) for 6 h at 37 -C p
VLPs for 45 min then stained with H11.H3. Scale bar represents 10 Am. (a, c, an
and TBP transcripts. Treatments did not affect RNA yields or Ct values for TBP (nnearly confluent HaCaT and COS-7 monolayers (Figs. 2b, c,
and d). These data support the hypothesis that HS plays a role
in the HPV-11 infection of HaCaT monolayers (Joyce et al.,
1999) but do not exclude the possibility that HPV-11 may also
infect this cell line via an HS-independent pathway as has been
shown for HPV-31b virions (Patterson et al., 2005).
Treatments that improve HPV-11 adsorption/infection using
confluent monolayers
As an additional method of investigating a possible role for
HS in the infection of monolayers of HaCaT and COS-7 cells,
confluent cells were cultured with sodium chlorate prior to
infection. Sodium chlorate has been shown to selectively
inhibit sulfotransferases resulting in a preferential inhibition of
the O-sulfation of GAGs during processing in the Golgi
apparatus (Safaiyan et al., 1999). Sodium chlorate pretreat-adsorption. (a) One day post-seeding, triplicate wells of confluent monolayers
again the subsequent day. After 42 h of treatment, monolayers were rinsed and
h later, and cells were given fresh medium containing H11.H3. (b) HaCaT cells
and incubated with HPV-11 L1 VLPs for 45 min. Coverslips were stained with
were pretreated with heparin (0–50 Ag/ml) for 6 h at 37 -C prior to rinsing and
nsed and given fresh medium containing H11.H3. (d) As above, duplicate wells
r 6 h prior to infection with HPV-11 virions. (e) Nearly confluent HaCaT cells
rior to rinsing and fixation. Monolayers were then incubated with HPV-11 L1
d d) RNA was harvested at 2 days p.i. and analyzed by QRT-PCR for E1^E4
ot shown). Asterisks (*) indicate P < 0.05 compared to mock-treated controls.
Fig. 4. Effect of trypsin digestion on HPV-11 infection and adsorption. (a)
Confluent monolayers grown for 1 or 3 days post-seeding were incubated on ice
then treated with PBS T trypsin. After 10 min, all monolayers were rinsed
repeatedly with cold PBS then incubated for 5 min with soybean trypsin
inhibitor in DMEM (10% FBS). Monolayers were then rinsed with PBS and
given fresh medium containing HPV-11 virions. At 12 h p.i., the monolayers
were rinsed and fed with medium containing H11.H3. (b) In an independent
experiment, duplicate wells of ‘‘1 day’’ HaCaT cells were treated and infected as
described above. (c) HaCaT monolayers seeded 1 day previously on coverslips
were treated with 0.1% trypsin as described above. Cells were kept on ice and
stained with anti-HS, or bound with HPV-11 L1 VLPs and CTX-B-FITC, for 1
h prior to methanol fixation. Coverslips treated with VLPs were subsequently
stained with H11.H3. Arrows indicate VLPs bound to areas between cells which
did not stain positive for CTX-B-FITC (membrane staining not shown). Nuclei
were stained with Hoechst 33342. Scale bar represents 10 Am. (a and b) RNA
was harvested 2 days p.i. and analyzed for E1^E4 and TBP transcripts.
Treatments did not affect RNAyields or Ct values of TBP (not shown). Asterisks
(*) indicate P < 0.05 compared to mock-treated controls.
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reduce infection of COS-7 cells by pseudovirions (Giroglou et
al., 2001) and adsorption of VLPs to HaCaT cells (Joyce et al.,
1999). Consistent with this observation, we found that 50 and
100 mM chlorate treatments reduced HPV-11 infection of both
HaCaT and COS-7 cells by 10-fold or greater (data not shown).
Unexpectedly, however, we reproducibly found that culture of
monolayers with 10 mM sodium chlorate resulted in an
increase in levels of E1^E4 transcripts in both HaCaT and
COS-7 cells (Fig. 3a). Consistent with the infectivity data,
immunocytochemistry revealed that 10 mM chlorate-treated
HaCaT monolayers showed an improved ability to bind VLPs
via an apical receptor, while the 50 and 100 mM treatments
reduced VLP binding (Fig. 3b). These data suggest that
improved adsorption by cells treated with 10 mM chlorate
might contribute to increased HPV-11 infection.
Previous reports indicate that heparin can bind to plasma
membranes via surface proteins expressed on keratinocytes
including CD44 (Cooper and Dougherty, 1995) and keratino-
cyte growth factor receptor (KGFR) (LaRochelle et al., 1999).
In order to explore the possible effect of membrane-associated
heparin on HPV-11 infection, uninfected HaCaT monolayers
were pretreated with heparin prior to infection with virions. An
escalating dosage experiment using concentrations of 0 to 50
Ag/ml heparin demonstrated a dose-dependent effect on HPV-
11 infection (Fig. 3c). Reproducibly, pretreatment with 10 Ag/
ml heparin significantly improved HPV-11 infection in both
HaCaT and COS-7 cells (Fig. 3d). Although heparin pretreat-
ment showed no obvious effect on expressed levels of HS, syn-
1, perlecan, or a6 integrin by immunocytochemistry (data not
shown), the heparin pretreatment of HaCaT monolayers
improved their ability to adsorb VLPs (Fig. 3e). These findings
are consistent with the hypothesis that plasma membrane-
associated heparin might be able to function as an HSPG-like
receptor for HPV-11 virions.
HPV capsids can adsorb to a component of the ECM secreted
by keratinocytes
The membrane-associated adsorption receptor for papillo-
maviruses is known to be trypsin-sensitive (Muller et al.,
1995; Volpers et al., 1995). In an effort to confirm this
conclusion using adherent cells in our HPV-11 infection
model, HaCaT and COS-7 monolayers were treated with
trypsin at 0 -C prior to infection with HPV-11. Confluent
monolayers of HaCaT cells seeded 1 or 3 days previously
both remained intact during the trypsin treatment, but,
unexpectedly, we saw improved infectivity following trypsin
treatment (Fig. 4a). Conversely, only the monolayers of COS-
7 cells seeded 1 day previously tolerated the incubation on ice
and showed a drop in infectivity with increasing trypsin
concentration. We reproducibly found that the trypsin
pretreatment of HaCaT monolayers significantly increased
the amount of HPV-11 protected from neutralization by a
neutralizing antibody at 12 h p.i. (Fig. 4b).
To investigate possible mechanisms for this unexpected
improvement in HPV-11 infection, HaCaT and COS-7monolayers grown on coverslips were pretreated with trypsin
at 0 -C followed by immunocytochemistry. While the trypsin
treatment eliminated the majority of HS staining and almost
all VLP binding to the apical surface, it also resulted in high
numbers of VLPs bound to areas exposed between HaCaT
cells (Fig. 4c). Subsequent experiments showed that these
VLPs colocalized with LN5, a marker of the ECM, but not
with HS or a6 integrin (data not shown, see Fig. 6b). No
VLP binding was observed between COS-7 cells treated with
trypsin, indicating that this basal ECM receptor is not secreted
by all cell lines.
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SV, KH-SV, and A431 cells using a high concentration of VLPs
(35 Ag protein/ml) revealed that the bulk of viral particles bound
to the basal ECM exposed at the edges of cell clusters (Fig. 5a).
This area was not stained by CTX-B-FITC. Additional experi-
ments showed that anti-LN5 bound subconfluent monolayers
with a similar pattern as seen with VLPs (data not shown). VLP
binding to the adjacent substratewas not observedwith 293T,CV-
1, COS-7, or C127 cells. Authentic HPV-11 virions bound
subconfluent HaCaTcellswith the same pattern as L1-onlyVLPs,
demonstrating that the L1-only VLPs are accurately modeling the
binding of authentic virions to these receptors. VLPs of all other
HPV types tested (6, 16, and 40) bound to the exposed ECM of
HaCaT cells similarly to the HPV-11 particles (data not shown).
Dilution experiments with subconfluent HaCaT cells
revealed that HPV-11 L1 VLPs and HPV-16 L1/L2 pseudovir-Fig. 6. VLPs colocalize with LN5 in the ECMs of cultured keratinoctyes. (a
Subconfluent cells were removed from glass coverslips 1 day post-seeding using
10 mM EDTA followed by gentle pipetting. Coverslips were then fixed with
methanol, incubated with HPV-11 L1 VLPs for 45 min, and then stained with
anti-LN5 (green) and anti-VLP rabbit serum (red). Cell removal is indicated by
the absence of Hoechst 33342 nuclear staining. The anti-VLP serum did no
stain the ECM on coverslips not treated with VLPs (not shown). Scale ba
represents 10 Am. (b) Subconfluent NHEK were removed from glass coverslips
using 10 mM EDTA and bound with HPV-11 L1 VLPs for 45 min. Coverslips
were then stained with anti-a6 integrin, anti-HS, or anti-LN5 (green) in addition
to anti-VLP rabbit serum (red). Cell removal is indicated by the lack of Hoechs
33342 nuclear staining. Similar results were obtained when anti-a6 integrin
anti-HS, or anti-LN5 antibodies were applied prior to VLP binding, indicating
no competitive binding by these MAbs. Scale bar represents 10 Am.Fig. 5. Preferential binding of HPV capsids to the exposed ECM. (a)
Subconfluent cells grown on coverslips were methanol-fixed and then bound
with HPV-11 L1 VLPs, or HPV-11 virions (8000 particles/cell, ‘‘HaCaT-
virions’’) for 45 min followed by staining with H11.H3 (red) and CTX-B-FITC
to indicate plasma membranes (green channel not shown for clarity). Arrows
indicate large numbers of virus particles bound to areas not stained by CTX-B-
FITC. Nuclei were stained with Hoechst 33342 (blue). VLPs bound similarly to
the substrate adjacent to BOUA-SV cells, but with less intensity than seen with
the other keratinocyte cell lines, while COS-7-like staining was seen in CV-1,
C127, and 293T cells (data not shown). All images were obtained with 2 s
exposures to allow the visualization of any membrane-bound VLPs. Scale bar
represents 10 Am. (b) Subconfluent HaCaT cells were fixed 1 day post-seeding
then incubated with 5-fold dilutions of HPV-11 L1 VLPs or 4-fold dilutions of
HPV-16 L1/L2 pseudovirions for 30 min. Cells were then stained with anti-L1
MAbs (H11.H3 and H16.7E) (red) and CTX-B-FITC to indicate the locations
of bound viral particles and the plasma membrane, respectively. Nuclei were
stained with Hoechst 33342 (blue). Arrows indicate HPV-11 VLPs bound to the
exposed ECM at the lowest concentration. Scale bar represents 50 Am. )
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,ions appear to bind the basal ECM receptor preferentially, with
binding to the apical receptor seen only with the higher
concentrations of viral particles (Fig. 5b). These data suggest
that the basal ECM receptor is distinct in structure or context
from the membrane-associated receptor and may indicate that
the affinity/avidity of the HPV capsids is higher for the basal
ECM receptor.
Removal of confluent or subconfluent NHEKs, HaCaT, KH-
SV, or A431 cells from glass or polystyrene with 10 mM EDTA
(or hypotonic treatment) left the basal ECM receptor on the
substrate. EDTA treatment can be used to remove keratinocytes
from the LN5-rich ECM secreted by these cells (Rousselle et
al., 1991). Staining of the basal ECM with anti-LN5 revealed
T.D. Culp et al. / Virology 347 (2006) 147–159 153that this ECM marker colocalized with the adsorbed VLPs with
NHEKs and all keratinocyte-derived cell lines (Fig. 6). While
the EDTA-resistant basal ECM bound all HPV particles tested,
it was not stained well by anti-a3 integrin, anti-a6 integrin,
anti-HS, anti-CD44, anti-syn-1, anti-perlecan, anti-BM-HSPG,
or FITC-CTX-B (Fig. 6 and data not shown).
VLP binding to coverslips following the removal of COS-7
cells by EDTA or hypotonic treatment was very weak compared
to that seen with the keratinocyte-derived cell lines. VLPs
bound to coverslips containing the COS-7 ECM generally
colocalized with anti-HS and with residual plasma membrane
stained with CTX-B-FITC. Few VLPs could be detected bound
to coverslips following removal of C127, CV-1, and 293T cells,
and no LN5 staining was observed with any of these cell lines.
It is unclear whether the weaker staining in COS-7 basal
ECM was due to receptor saturation or low affinity/avidity as
high quantities of HPV particles were applied in these
experiments. Few VLPs bound to coverslips following the
removal of HaCaT and COS-7 cells by trypsin treatment or
mechanical scraping.
HPV capsids bind the basement membrane of human cervical
mucosa
To test the hypothesis that the basal ECM adsorption
receptor may play a role in natural HPV infections of humanFig. 7. Binding of HPV particles to the BM of human cervical tissue sections. (a) L1
with fixed sections of cervical tissue for 20 min. Sections were then stained with a V
of cervical mucosa was indicated by H and E staining (not shown). The basal layer
parallel to it. (b) HPV-11 L1 VLPs were incubated with sequential sections of cerv
Identical conditions and exposure times were utilized. The position of the basal lay
clarity), is indicated by a white arrow drawn parallel to it prior to the elimination of
were bound with HPV-6 VLPs (green) or a MAb specific for the indicated marker
layer, as determined by nuclear staining (blue), is indicated by white arrows. Barsepithelium, sections of frozen human cervix were bound with
VLPs. A previous report revealed no obvious binding of
HPV6b VLPs to the basement membrane (BM) of monkey
esophageal mucosa (Evander et al., 1997). As predicted by the
in vitro data using human keratinocyte cell lines, however,
HPV-6, HPV-11, HPV-16, and HPV-18 particles all showed the
ability to bind a receptor in the BM (Fig. 7a). Consistent with
the VLP dilution experiments performed with subconfluent
HaCaT cells, increasing the incubation period of VLPs with
cervical tissue sections increased staining of the suprabasal
layers of the epithelium (Fig. 7b). This suggests that the viral
capsids preferentially adsorb to a BM receptor and bind to a
distinct receptor on suprabasal keratinocytes after saturation of
the BM receptor.
To determine if VLPs colocalized with LN5 at the BM, as
seen with the in vitro experiments using cultured keratinocytes,
we first attempted costaining for LN5 and bound VLPs. This
approach yielded uncertain results, however, due to high levels
of nonspecific staining by the anti-VLP rabbit antiserum. As an
alternative approach, sequential sections of human cervical
mucosa were bound either with VLPs (followed by an anti-L1
MAb) or with MAbs targeting LN5, HS, a3 integrin, or a6
integrin (Fig. 7c). Although the cervical mucosa BM was
stained by all MAbs tested, the very restricted staining of LN5
more closely matched the VLP binding pattern than did the
staining of HS, a3 integrin, or a6 integrin.VLPs of HPV-6, -11, or -18 or L1/L2 pseudovirions of HPV-16 were incubated
LP-specific MAb (red). Normal morphological architecture of adjacent sections
, as determined by nuclear staining (blue), is indicated by a white arrow drawn
ical tissue for the selected timepoints followed by staining with H11.B2 (red).
er, as determined by Hoechst 33342 staining of nuclei (not shown for greater
the blue channel. (c) Sequential sections (left to right) of human cervical tissue
(red) for 20 min. Inserts show photos taken at higher magnification. The basal
of inserts represent 10 Am, all other bars represent 50 Am.
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Because the basal ECM of HaCaT cells was poorly stained
by anti-HS in our immunocytochemistry experiments, we
hypothesized that particle binding to the ECM receptor is
HS-independent and therefore may not be blocked by heparin
pretreatment of virus particles. Pretreatment of VLPs with
heparin showed little effect on their ability to bind the exposed
ECM of HaCaT cells but effectively blocked VLP binding tothe plasma membrane (Fig. 8a). An ELISA-based binding
assay using fixed HaCaT cells and ECM was also performed.
When methanol fixation was utilized, heparin pretreatment of
VLPs only weakly inhibited VLP binding to the confluent
HaCaT cells (Fig. 8b). Because this result was incongruous
with reproducible immunocytochemistry data (Fig. 2), we
hypothesized that cell contraction caused by methanol fixation
may have exposed areas of the ECM. Due to the high binding
capacity of the basal ECM receptor (Fig. 8a), the exposure of
even small patches of ECM could result in the binding of large
numbers of VLPs. An attempt at performing the assay using
live cells maintained at 4 -C was ineffective due to sloughing at
the edges of the monolayers. We therefore performed the
experiment using the cross-linking fixative paraformaldehyde
as described previously (Joyce et al., 1999) (Fig. 8b). This
assay yielded results consistent with immunocytochemistry in
that VLP binding to the apical receptor was effectively blocked
by heparin, while binding to the basal ECM receptor was
refractory to this treatment (Fig. 8b).
We next sought to determine whether virions preadsorbed to
the basal ECM receptor could successfully infect cells.
Confluent monolayers of HaCaT and COS-7 cells were
removed from 6-well plates using EDTA, and the residual
ECM was then preadsorbed with authentic HPV-11 virions,
some of which had been pretreated with heparin. After rinsing
to remove unattached virions, wells were seeded with uninfect-
ed HaCaT or COS-7 cells. By visual inspection, we determined
that HaCaT cells grew best on the HaCaT ECM substrate, while
COS-7 cells attached and grew equally well on either ECM.
Consistent with our immunocytochemistry findings, the relative
levels of viral transcripts indicated that cells seeded onto the
HaCaT ECM were infected by more virions that those seeded
onto the COS-7 ECM or the EDTA-treated control wells (Fig.
8c). Contrary to our hypothesis, however, the heparin pretreat-
ment of virions successfully blocked infection similarly as withFig. 8. Effect of heparin on adsorption and infection via the basal ECM
receptor. (a) HPV-11 L1 VLPs were incubated T heparin (7 mg/ml) for 1 h prio
to dilution and incubation (45 min) with methanol-fixed subconfluent HaCaT
cells. Coverslips were then stained with H11.B2, CTX-B-FITC (not shown fo
clarity), and Hoechst 33342. Scale bar represents 10 Am. (b) Triplicate wells
(96-well format) containing confluent HaCaT cells or their EDTA-resistan
ECM were fixed with 4% paraformaldehyde (PFA) or methanol (MeOH) prio
to incubation with VLPs pretreated with 5-fold dilutions of heparin. Values on
the abscissa represent heparin concentrations during the incubation period
with VLPs prior to dilution and application to triplicate wells. Values on the
ordinate (means T SEM) represent percent signal (405 nm) relative to
identical control wells bound with untreated VLPs. Bound VLPs were
detected using H11.B2. (c) HPV-11 virions (900 particles per subsequently
seeded cell) were incubated T heparin (4 mg/ml) for 1 h. Treated virus was
diluted in culture medium and adsorbed for 6 h at 37 -C to the ECMs of HaCaT
(H-ECM) or COS-7 (C-ECM) monolayers removed immediately prior (using 10
mM EDTA). Following the adsorption period, the substrates were rinsed
repeatedly to remove unbound virions. Fresh HaCaT or COS-7 cells were then
seeded, in duplicate, onto the substrates preadsorbed with virions. RNA was
harvested 2 days p.i. for analysis by QRT-PCR for E1^E4 transcripts. Relative
comparisons of E1^E4 transcript levels can only be made within a given cell line
as the ordinate values are determined relative to viral transcript levels present in
the same cell line infected by virions adsorbed to EDTA-treated polystyrene
(EDTA-PS). Heparin did not affect RNAyields or Ct values of TBP (not shown)
Asterisks (*) indicate P < 0.05 compared to mock-treated controls.r
r
t
r
.
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It is unclear whether the 4-fold reduction in infection caused by
heparin pretreatment of HPV-11 virions in Fig. 8c is due solely
to reduced particle adsorption.
Discussion
Papillomavirus particles bind to a wide variety of cell lines
(Muller et al., 1995) presumably via a shared receptor (Roden et
al., 1994). Adsorption of HPV particles is known to occur via
interactions with a6 integrin (Evander et al., 1997; McMillan et
al., 1999; Yoon et al., 2001) or HS (Combita et al., 2001; Drobni
et al., 2003; Giroglou et al., 2001; Joyce et al., 1999; Shafti-
Keramat et al., 2003). While the mechanism of interaction
between the viral capsid and the former receptor is unknown,
there is controversial evidence that a conserved cluster of basic
residues on the carboxyl terminus of L1 is involved in
nonspecific binding to highly sulfated, negatively charged
moieties of HS (Giroglou et al., 2001; Joyce et al., 1999).
Although both a6 integrin and HS can function as HPV
receptors, neither appears to be an obligate receptor, at least for
all viral types. Cells not expressing a6 integrin can be infected
by papillomavirus virions and pseudovirions (Giroglou et al.,
2001; Shafti-Keramat et al., 2003; Sibbet et al., 2000).
Analogous data showed that neither the removal of cell surface
HS by heparinase I nor the pretreatment of virions with heparin
reduced HPV-31b infection of subconfluent HaCaT cells, N/
TERT-1 cells, and human foreskin keratinocytes (Patterson et
al., 2005). Supporting the case for cell line differences in HPV
receptors, the infection of both C-33A and COS-7 cells by
HPV-31b virions was strongly inhibited by heparinase I and
heparin (Patterson et al., 2005).
Our data suggest that adherent keratinocyte cell lines possess
two distinct receptors, one expressed on the apical surface of
monolayers and the other secreted into the basal ECM (Fig. 5a).
It seems likely that, when infection experiments utilize confluent
monolayers of keratinocyte-derived cell lines, only the mem-
brane-associated receptor is available for adsorbing virions,
while both the membrane-associated and basal ECM receptors
may participate in viral adsorption by subconfluent cells. In the
latter case, our data suggest that HPV particles may show
preferential binding for the exposed basal ECM receptor (Fig. 5).
Membrane-associated VLP receptors on suspended HeLa cells
were previously shown to be saturated by approximately 2 104
particles per cell (Volpers et al., 1995). Our immunocytochem-
istry data suggest that the VLP binding capacity of the basal
ECM receptor is likely to be higher.
Distinct from the recently reported findings for HPV-31b
infection of subconfluent HaCaT cells, our data indicate that
the treatment of confluent HaCaT monolayers with heparinase
I, or a competing HS ligand, or the pretreatment of virions with
heparin can reduce infection by HPV-11 (Figs. 1 and 2). These
results are consistent with the hypothesis that HS plays a role in
the adsorption of HPV-11 virions to the apical surface of
HaCaT monolayers (Joyce et al., 1999). This finding is also in
agreement with HS-mediated infection of KH-SV keratinocytes
by HPV-11 virions (Shafti-Keramat et al., 2003).The magnitude of the effect of the various treatments
targeting cell surface HS may have been greater had virions
been given less time to attach. Due to the slow adsorption rate
of HPV-11 virions to these cell lines (Culp and Christensen,
2004), we allowed 6 h for viral adsorption following the end of
the pretreatment period. A shorter adsorption period would
allow less monolayer recovery from the pretreatment but would
also result in reduced infection. With this HPV-11 infection
model, assaying viral E1^E4 transcripts with QRT-PCR gives a
linear relationship between input virions and viral transcripts
but is less sensitive than ‘‘nested’’ RT-PCR (Culp and
Christensen, 2003). The 6 h post-adsorption period following
the pretreatment period reduced the possibility of direct effects
of the treatment on the virions themselves and allowed
sufficient virions to adsorb to support a quantitative measure-
ment of HPV-11 infection. Differences seen between HaCaT
and COS-7 cells, therefore, could be at least partially due to
faster recovery of cell surface HS by HaCaT cells following the
removal of treatment. The fact that the 6 h adsorption period
allows for at least a degree of monolayer recovery in the
presence of the inoculum favors the null hypothesis.
Two pretreatments of confluent monolayers increased HPV
adsorption/infection via the apical surface. Although pretreat-
ing virus particles with heparin inhibited infection (Fig. 2),
the pretreatment of uninfected monolayers with heparin
resulted in increased adsorption and infection by HPV-11
(Fig. 3). One possible explanation of this result is that the
association between heparin and heparin-binding proteins
such as CD44 and KGFG (Cooper and Dougherty, 1995;
LaRochelle et al., 1999) might form HSPG-like molecules
(Embry and Knudson, 2003; Zhou et al., 1997) which can
capture HPV-11 particles and directly or indirectly facilitate
their endocytosis. Pretreatment of monolayers with 10 mM
sodium chlorate also increased HPV-11 infection (Fig. 3),
although the mechanism and relevance of this finding are also
unclear.
While in vitro HPV infection of confluent monolayers
appears to involve an undetermined membrane-associated
HSPG which is generally expressed by eukaryotic cells, the
basal ECM adsorption receptor was secreted only by the
keratinocyte cell lines (Fig. 6). The basal ECM of keratinocytes
was not stained well by anti-a6 integrin, anti-HS, nor by
antibodies against four different HSPGs, and binding of VLPs
to the ECM was refractory to heparin pretreatment. We
hypothesize that the basal ECM receptor is an HS-independent
mechanism of HPV adsorption (Patterson et al., 2005).
Experiments with HPV-11 virions demonstrated that the basal
ECM receptor does not merely sequester virions but can
function during in vitro infection (Fig. 8c).
It should be stressed that, while we have sought to use
fluorescent microscopy to give insight into our infectivity data,
there are substantial differences between the two types of
experiments including virus particle type (e.g. L1-only VLPs
vs. virions), length of adsorption period (minutes vs. hours),
and the condition of cells (fixed vs. live). Our in vitro infection
model utilizing QRT-PCR is useful at relatively low m.o.i.
compared to the extremely high particle-to-cell ratio required
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entry kinetics, pathway, or adsorption receptor.
Similar patterns of VLP binding and LN5 staining at the BM
of cervical mucosa (Fig. 7c) and to the ECM of cultured
keratinocytes (Fig. 6) make LN5 a logical first candidate for the
secreted adsorption receptor in the ECM of keratinocytes. LN5
is a unique variant of laminin composed of a3 h3 and g2
chains. The latter two subunits are unique to LN5, while the a3
chain is also found in LN6, LN7, and LN13. Modules on the
globular domain at the carboxyl terminus of the a3 chain have
been shown to interact with a6 integrin, syndecans, and
heparin (Utani et al., 2001). Two previous papers describe
conflicting results when using human laminin to block VLP
adsorption to HaCaT cells (Evander et al., 1997; Joyce et al.,
1999). Commercially available human laminin has been shown
to contain laminins 10 and 11 which are composed of a5h1g1
and a5h2g1 chains, respectively (Ferletta and Ekblom, 1999).
LN5 is the primary laminin secreted by migrating and basal
layer keratinocytes.
In order to access the mitotically active keratinocytes of the
basal layer, HPV virions must breach the suprabasal layers at a
site of wounding. Multiple membrane-associated HSPGs, such
as syndecans, CD44, and glypican, are highly expressed
throughout the suprabasal layers of unwounded epithelium
(Lundqvist and Schmidtchen, 2001; Oksala et al., 1995).
Immunohistochemistry demonstrated that VLPs of HPV-6, -11,
-16, and -18 bound quickly to the BM of human cervical
mucosa (Fig. 7a). Longer incubation times led to additional
staining throughout the mucosa (Fig. 7b). This suggests that
HPVs may show preferential binding to viral receptors in the
BM (Fig. 7c). Although not indicated in our immunocyto-
chemistry experiments, it is possible that HS present in the BM
can function to bind VLPs with higher avidity than HS found
in suprabasal mucosa. Evidence for structural or contextual
differences in ligand binding to HSPGs in human skin has been
shown with FGF-2 and soluble FGF-receptor (Chang et al.,
2000).
After wounding, the expression of HSPGs throughout the
suprabasal layers is rapidly downregulated (Andriessen et al.,
1997; Oksala et al., 1995). Consistent with this observation,
wounding of human skin rapidly triggers the disappearance of
at least two HS epitopes (Andriessen et al., 1997). Staining for
basement membrane HSPGs also disappears from both skin
and mucosa following the wounding event (Andriessen et al.,
1997; Oksala et al., 1995). By distinction, migrating keratino-
cytes express high levels of several HSPGs, including syn-1
and CD44 (Oksala et al., 1995). Additionally, these mitoticallyFig. 9. Model for natural infection of wounded epithelium. (a) Microwounds in
the epithelium permit viral particles (circles) access to HS moieties throughout
the mucosa or skin. (b) Wounding induces reduced expression of HS and
HSPGs (asterisks) throughout the epithelium resulting in decreased avidity
between adsorbed virions and suprabasal cells. (c) Some virus particles are
transiently adsorbed to the ECM receptor (triangles) secreted by migrating
keratinocytes (MK) as they infiltrate the wound and repair the basement
membrane. (d) The transfer of adsorbed capsids from the ECM receptor to a
membrane-associated receptor facilitates the endocytosis of HPV virions by
mitotically active cells of the reestablished basal layer.
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1998) which is detectable within hours following the wounding
event and prior to the secretion of other BM components such
as type VII collagen and BM-HSPG (reviewed in Nguyen et
al., 2000).
We propose a model of papillomavirus infection in which
virions are initially adsorbed throughout the wounded epithe-
lium and then transferred, via a transient association with the
secreted ECM receptor, to mitotically active migrating kerati-
nocytes which invade the wound to reestablish the basal layer
and BM (Fig. 9). The transfer of virions to migrating
keratinocytes is facilitated by the slow uptake of adsorbed
HPV virions (Christensen et al., 1995; Culp and Christensen,
2004; Selinka et al., 2002), the downregulation of HS and
HSPG by suprabasal keratinocytes following a wounding event
(Andriessen et al., 1997; Oksala et al., 1995), and the
expression of both secreted and transmembrane adsorption
receptors by migrating keratinocytes (Lampe et al., 1998;
Oksala et al., 1995). While heparin treatment of HPV particles
did not completely block adsorption to the basal ECM receptor,
it inhibited subsequent infection (Fig. 8). It is unclear whether
an HS-dependent step is involved in the transfer of virions from
the ECM to the plasma membrane and/or an HS-independent
step is inhibited by the heparin coating of virions.
The presence of an HPV receptor secreted by keratinocytes
into the basal ECM may contribute to the developing model of
natural papillomavirus infection by helping to connect in vitro
observations with in vivo events occurring in the wounded
epithelium. The characterization of this keratinocyte-specific
secreted adsorption receptor is currently under investigation in
our laboratory. Unlike COS-7 cells which have repeatedly been
shown to be limited to infection through an HS-dependent
mechanism (Giroglou et al., 2001; Patterson et al., 2005), our
data suggest that subconfluent cultured human keratinocytes
may be infected by virions adsorbed to the apical surface or to
the exposed ECM at the edges of cell clusters. Because it
appears that at least two distinct and functional adsorption
receptors are expressed by keratinocytes, it is unlikely that
infection would be fully blocked by strategies targeting HS, a6
integrin, or the basal ECM receptor. Successful infection of
keratinocytes lacking accessible HS (e.g. heparinase I-treated),
a6 integrin (e.g. confluent monolayers or BOUA-SV), or basal
ECM receptor (e.g. confluent monolayers) probably indicates
that no single adsorption receptor is essential for HPV
infection. It has yet to be shown how our current understanding
of papillomavirus entry, based largely on research from
infection models utilizing non-keratinocytes, confluent kerati-
nocytes, and suspended cells will apply to the entry of viral
particles following adsorption to the secreted HPV receptor in
the ECM of keratinocytes.
Materials and methods
Cells, virus particles, and reagents
HaCaT cells (spontaneously immortalized human keratino-
cytes from skin) (Boukamp et al., 1988) were cultured inDMEM containing 10% FBS. CV-1 (green monkey kidney),
COS-7 (CV-1 immortalized with SV40), A431 (epidermoid
carcinoma from vulva), 293T (adenovirus-immortalized human
embryo kidney cells expressing SV40 LTAg), and C127 cells
(mouse mammary tumor) were each cultured in DMEM
containing 5% FBS. NHEKs (Clonetics), KH-SV (human
keratinocytes immortalized with SV40), and BOUA-SV cells
(human keratinocytes not expressing a6 integrin and immor-
talized with SV40) (Miquel et al., 1996) were each maintained
in KGM (Cambrex). Unless noted, cells were seeded at 0.5 to
1  106 cells/well in 6-well plates and infected or fixed 1 day
post-seeding when >90% confluent. For sodium chlorate
experiments, cells were given fresh medium T treatment on
days 1 and 2. Cells were then infected or fixed on day 3.
HPV-11 stocks were produced in human xenografts trans-
planted into immunocompromised mice as previously de-
scribed (Kreider et al., 1987). VLPs were produced using
insect cells infected with recombinant baculoviruses encoding
L1 as previously described (Christensen et al., 1994).
Pseudovirions used for immunofluorescent studies were
produced in 293TT cells transfected with plasmids encoding
both capsid proteins and a pseudogenome as described
previously (Buck et al., 2004). VLPs and pseudovirions used
for immunocytochemistry and immunohistochemistry were
found by ELISA to contain proper L1 confirmation as
indicated by a lack of binding by H16.D9, a MAb targeting
a buried linear sequence (Christensen et al., 1996). Neutral-
ization of HPV-11 was accomplished by H11.H3 (IgG2b)
used in excess at a concentration of 2.8 Ag/ml. Heparin
(H1027), protamine (P4005), sodium chlorate (S3171),
heparinase I (H2519), and trypsin inhibitor (T6414) were
purchased from Sigma-Aldrich.
Immunocytochemistry
All immunocytochemistry was performed using fixation with
20 -C methanol and incubations with 2% BSA/PBS (pH 7.4)
as diluent and wash buffer. Pilot experiments demonstrated no
obvious differences in the appearance of membrane markers of
live cells stained at 0 -C prior to fixation and those on cells
stained following fixation, therefore pre-fixation was utilized
unless otherwise noted. Mouse monoclonal antibodies (MAb)
used for these studies were: anti-human epiligrin (LN5)
(Chemicon, P3E4), anti-HSPG (BM-HSPG) (Chemicon,
7E12), anti-CD138 (syn-1) (Immunotech, B-B4), anti-perlecan
(Zymed, 7B5), anti-HS (Seikagaku, F58-10E4), anti-human
CD44 (Sigma, A3D8), and P1F2 (anti-a3 integrin) (a gift from
W.G. Carter, FHCRC). The single rat MAb utilized was anti-
CD49f (a6 integrin) (BD PharMingen, GoH3). VLPs were used
at a concentration of approximately 15 Ag protein/ml unless
otherwise noted. Anti-VLPMAbs (H6.B10.5, H11.H3, H11.B2,
H16.V5, H16.7E, and H18.J4) each recognize a conformation-
ally dependent epitope of L1. These MAbs do not detect
denatured VLPs or L1 monomers. Rabbit anti-serum (C0806)
generated against HPV-11 was previously described (Christen-
sen et al., 2002). Fluorescently stained secondary antibodies
utilized were anti-mouse Alexa Fluor 488, anti-mouse Alexa
T.D. Culp et al. / Virology 347 (2006) 147–159158Fluor 594, anti-rat Alexa Fluor 568 (Molecular Probes), and
Texas Red-conjugated goat anti-rabbit (Jackson). Nuclear
staining was performed in all experiments using Hoechst
33342 (1 Ag/ml) (Molecular Probes). Where indicated, FITC-
conjugated CTX-B (Sigma) was used as a nonspecific
membrane stain (4 Ag/ml). Appropriate antibody, VLP, and
pseudovirus dilutions were empirically determined. Fluores-
cent microscopy was performed on the Nikon Eclipse E600.
Photos were prepared using Adobe Photoshop. All figures
within an individual panel were exposed and digitally prepared
in identical manners.
Immunohistochemistry
Subclinical human cervical tissue was obtained from
anonymous donors. Samples were snap frozen and cryosec-
tioned at 8 Am. Post-fixed in cold acetone, sections were
incubated with reagents described above diluted in 2% BSA/
PBS (pH 7.4).
Infection assays
Heparinase I digestion (Fig. 1) was performed in an
isotonic buffer containing KCl (10 mM KCl, 130 mM NaCl,
20 mM HEPES, 1 mM CaCl2, 1 mM MgCl2, 1 mg/ml
glucose, and 0.5% BSA, pH 7.4) in order to avoid disruption
of clathrin-mediated endocytosis (Bayer et al., 2001). For all
experiments utilizing confluent monolayers, cells were
infected with 150 HPV-11 virus particles/cell. For basal
infection by substrate-adsorbed virions (Fig. 8), 900 viral
particles/cell were added to cell-free wells 6 h prior to rinsing
and subsequent seeding. Total RNAs were harvested using
TRIzol (Invitrogen). Bars on graphs represent means T SEM
of viral transcript levels measured in the RNAs from
companion monolayers. Where indicated, asterisks (*) indi-
cate P < 0.05 by Student’s t test relative to vehicle-treated
(‘‘mock’’) controls. QRT-PCR was performed as previously
described (Culp and Christensen, 2003). Levels of HPV-11
E1^E4 transcripts were compared based on the levels of an
endogenous reference transcript (TATA binding protein
(TBP)). RNAs were assayed in multiplex reactions for the
levels of TBP and viral transcripts using Quantitect Probe RT-
PCR Kit (Qiagen). Amplification primers (Integrated DNA
Technologies) and Taqman probes (Biosearch Technologies)
for TBP and HPV-11 E1^E4 were used as previously
described (Culp and Christensen, 2003).
ELISA-based VLP binding assay
The effect of heparin on VLP binding to fixed cells was
performed as previously described (Joyce et al., 1999) with the
some alterations. HaCaT cells were seeded at 5  104/well in
96-well plates and fixed with ice-cold methanol or 4%
paraformaldehyde 1 day later when confluent. Prior to fixation,
cells on half of the plate were removed by a 10 min treatment
with 10 mM EDTA and pipetting to expose residual ECM.
HPV-11 L1 VLPs (500 ng/well) were preincubated Theparin(for 1 h at RT) at the concentrations shown, while the plate was
blocked with 1% milk (PBS). Following dilution with blocking
agent, VLPs were applied to triplicate wells for 1 h to allow
binding. Bound VLPs were detected using H11.B2, anti-mouse
secondary conjugated to alkaline phosphatase, and p-nitrophe-
nyl phosphate.
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